Executive Summary Ecstasy - In 2023, data were collected from April to June. Interviews between 2020

There was also a significant change in 1 Ecstasy and Related Drugs Reporting System 2023 9% in 2007 to 47% in 2023, although the figure participants (n≤5) reported recent use of DMT for 2023 represents a significant decrease from in 2023, a significant decrease from 18% in 64% in 2022 (p=0.022). [...] There Products was also a significant decrease in reported Sixty-seven per cent of the sample reported recent use of hallucinogenic mushrooms recent use of non-prescribed cannabis in 2023, (49%; 64% in 2022; p=0.049). [...] Frequency of use also significantly Drug-Related Harms and Other decreased from a median of 33 days of use in Behaviours the previous six months in 2022 to 24 days in Most participants (86%) reported concurrent 2023 (p=0.045). [...] Hazardous alcohol use remained 82% in 2023, although frequency of use in the common, with 74% of the sample scoring previous six months significantly decreased above the hazardous range in the Alcohol Use from a median of 10 days in 2022 to six days Disorders Identification Test (AUDIT). [...] There was a significant fall in the (80%) reported engaging in some form of proportion of participants reporting LSD sexual activity in the past four weeks, of whom purity to be ‘high’ in 2023 (39%; 59% in 2022, 82% reported use of alcohol/drugs before or p=0.049).